These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38413424)

  • 1. High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancer.
    Göbel A; Rachner TD; Hoffmann O; Klotz DM; Kasimir-Bauer S; Kimmig R; Hofbauer LC; Bittner AK
    Arch Gynecol Obstet; 2024 Jun; 309(6):2789-2798. PubMed ID: 38413424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum levels of periostin are associated with a poor survival in breast cancer.
    Rachner TD; Göbel A; Hoffmann O; Erdmann K; Kasimir-Bauer S; Breining D; Kimmig R; Hofbauer LC; Bittner AK
    Breast Cancer Res Treat; 2020 Apr; 180(2):515-524. PubMed ID: 32040688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
    Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
    J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
    Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
    Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer.
    Chi Y; Yao L; Hu X; Huang S; Huang N; Li S; Shao Z; Wu J
    Oncotarget; 2016 Mar; 7(12):14951-62. PubMed ID: 26908452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand.
    Weivoda S; Andersen JD; Skogen A; Schlievert PM; Fontana D; Schacker T; Tuite P; Dubinsky JM; Jemmerson R
    J Immunol Methods; 2008 Jul; 336(1):22-9. PubMed ID: 18436231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and Predictive Value of Circulating and Disseminated Tumor Cells in Breast Cancer: A National Cancer Database (NCDB) Analysis.
    Bilani N; Elson L; Liang H; Elimimian EB; Arteta-Bulos R; Nahleh Z
    Technol Cancer Res Treat; 2020; 19():1533033820980107. PubMed ID: 33287661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Impact of Leucine-Rich α-2-Glycoprotein-1 in Cholangiocarcinoma and Its Association With the IL-6/TGF-β1 Axis.
    Jin Z; Kobayashi S; Gotoh K; Takahashi T; Eguchi H; Naka T; Mori M; Doki Y
    J Surg Res; 2020 Aug; 252():147-155. PubMed ID: 32278969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer.
    Rachner TD; Kasimir-Bauer S; Göbel A; Erdmann K; Hoffmann O; Browne A; Wimberger P; Rauner M; Hofbauer LC; Kimmig R; Bittner AK
    Clin Cancer Res; 2019 Feb; 25(4):1369-1378. PubMed ID: 30425091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
    Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
    Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
    Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.
    Shinzaki S; Matsuoka K; Iijima H; Mizuno S; Serada S; Fujimoto M; Arai N; Koyama N; Morii E; Watanabe M; Hibi T; Kanai T; Takehara T; Naka T
    J Crohns Colitis; 2017 Jan; 11(1):84-91. PubMed ID: 27466171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of increased serum leucine-rich α2-glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A retrospective study.
    Ishida T; Kotani T; Serada S; Fujimoto M; Takeuchi T; Makino S; Naka T
    PLoS One; 2020; 15(6):e0234090. PubMed ID: 32479560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.
    Falck AK; Bendahl PO; Ingvar C; Isola J; Jönsson PE; Lindblom P; Lövgren K; Rennstam K; Fernö M; Rydén L
    BMC Cancer; 2012 Sep; 12():403. PubMed ID: 22963449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis.
    Serada S; Fujimoto M; Terabe F; Iijima H; Shinzaki S; Matsuzaki S; Ohkawara T; Nezu R; Nakajima S; Kobayashi T; Plevy SE; Takehara T; Naka T
    Inflamm Bowel Dis; 2012 Nov; 18(11):2169-79. PubMed ID: 22374925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum leucine-rich α2-glycoprotein is elevated in patients with systemic lupus erythematosus and correlates with disease activity.
    Ahn SS; Park Y; Jung SM; Song JJ; Park YB; Lee SW
    Clin Chim Acta; 2018 Nov; 486():253-258. PubMed ID: 30118672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease.
    Yoshimura T; Mitsuyama K; Sakemi R; Takedatsu H; Yoshioka S; Kuwaki K; Mori A; Fukunaga S; Araki T; Morita M; Tsuruta K; Yamasaki H; Torimura T
    Mediators Inflamm; 2021; 2021():8825374. PubMed ID: 33623482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer.
    Furukawa K; Kawamoto K; Eguchi H; Tanemura M; Tanida T; Tomimaru Y; Akita H; Hama N; Wada H; Kobayashi S; Nonaka Y; Takamatsu S; Shinzaki S; Kumada T; Satomura S; Ito T; Serada S; Naka T; Mori M; Doki Y; Miyoshi E; Nagano H
    Pancreas; 2015 Jan; 44(1):93-8. PubMed ID: 25058884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis.
    Hartkopf AD; Brucker SY; Taran FA; Harbeck N; von Au A; Naume B; Pierga JY; Hoffmann O; Beckmann MW; Rydén L; Fehm T; Aft R; Solà M; Walter V; Rack B; Schuetz F; Borgen E; Ta MH; Bittner AK; Fasching PA; Fernö M; Krawczyk N; Weilbaecher K; Margelí M; Hahn M; Jueckstock J; Domschke C; Bidard FC; Kasimir-Bauer S; Schoenfisch B; Kurt AG; Wallwiener M; Gebauer G; Klein CA; Wallwiener D; Janni W; Pantel K
    Eur J Cancer; 2021 Sep; 154():128-137. PubMed ID: 34265505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.